Chapter 1. BIOLOGICAL SAFETY MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. BIOLOGICAL SAFETY MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. BIOLOGICAL SAFETY MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. BIOLOGICAL SAFETY MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. BIOLOGICAL SAFETY MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. BIOLOGICAL SAFETY MARKET– By Product

6.1. Reagents and Kits

6.2. Instruments

6.3. Others

Chapter 7. BIOLOGICAL SAFETY MARKET– By Application

7.1. Blood and Blood-based Therapy

7.2. Cellular and Gene Therapy

7.3. Vaccines and Therapeutics

7.4. Others

Chapter 8. BIOLOGICAL SAFETY MARKET– By Test

8.1. Bioburden Tests

8.2. Endotoxin Tests

8.3. Sterility Tests

8.4. Others

Chapter 9. BIOLOGICAL SAFETY MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. BIOLOGICAL SAFETY MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10